S
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
Price:
36.89
CNY
1.29%
Market Closed
Market Cap:
¥15.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
|
CN |
|
P
|
Protean eGov Technologies Ltd
BSE:544021
|
IN |
|
Diamondback Energy Inc
NASDAQ:FANG
|
US |
|
Zhejiang Jinke Tom Culture Industry Co Ltd
SZSE:300459
|
CN |
|
S
|
Sichuan Anning Iron and Titanium Co Ltd
SZSE:002978
|
CN |
|
Spacenet Enterprises India Ltd
NSE:SPCENET
|
IN |
|
P
|
Puma SE
OTC:PUMSY
|
DE |
|
F
|
Fractal Gaming Group AB
F:5HS
|
SE |
|
Canon Inc
OTC:CAJFF
|
JP |
|
MongoDB Inc
NASDAQ:MDB
|
US |
|
G
|
Guinness VCT PLC
LSE:GVCT
|
UK |
|
Bank Aladin Syariah Tbk PT
IDX:BANK
|
ID |
Multiples-Based Value
The Multiples-Based Value of one Shandong Weigao Blood Purification Products Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 36.89 CNY, Shandong Weigao Blood Purification Products Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Shandong Weigao Blood Purification Products Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Shandong Weigao Blood Purification Products Co Ltd Competitors
Shandong Weigao Blood Purification Products Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
|
15.4B CNY | 4.3 | 34.3 | 30.3 | 30.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.8B USD | 4 | 27.1 | 15.5 | 21.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.8B USD | 16 | 56.3 | 42.6 | 52.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127B USD | 5.1 | 39.1 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.9B USD | 3.1 | 24 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
91.7B USD | 4.6 | 31.7 | 18.8 | 25.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.9B USD | 7.7 | 43.7 | 24 | 26.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.5B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.8B USD | 10.6 | 43.3 | 30.7 | 33.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 2 | 25.1 | 10 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
